Cargando…

Prediabetes and the risk of breast cancer: a meta-analysis

BACKGROUND: Diabetes has been related to a higher risk of breast cancer (BC) in women. However, it remains unknown whether the incidence of BC is increased in women with prediabetes. A systematic review and meta-analysis was therefore performed to evaluate the relationship between prediabetes and ri...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Jing, Tu, Rongzu, Lu, Zhai’e
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10544966/
https://www.ncbi.nlm.nih.gov/pubmed/37790752
http://dx.doi.org/10.3389/fonc.2023.1238845
_version_ 1785114581493874688
author Lin, Jing
Tu, Rongzu
Lu, Zhai’e
author_facet Lin, Jing
Tu, Rongzu
Lu, Zhai’e
author_sort Lin, Jing
collection PubMed
description BACKGROUND: Diabetes has been related to a higher risk of breast cancer (BC) in women. However, it remains unknown whether the incidence of BC is increased in women with prediabetes. A systematic review and meta-analysis was therefore performed to evaluate the relationship between prediabetes and risk of BC. METHODS: Observational studies with longitudinal follow-up relevant to the objective were found via searching Medline, Embase, Cochrane Library, and Web of Science. A fixed- or random-effects model was used to pool the results depending on heterogeneity. RESULTS: Eight prospective cohort studies and two nest case-control studies were included. A total of 1069079 community women were involved, and 72136 (6.7%) of them had prediabetes at baseline. During a mean duration follow-up of 9.6 years, 9960 (0.93%) patients were diagnosed as BC. Pooled results with a fixed-effects model showed that women with prediabetes were not associated with a higher incidence of BC as compared to those with normoglycemia (risk ratio: 0.99, 95% confidence interval: 0.93 to 1.05, p = 0.72) with mild heterogeneity (p for Cochrane Q test = 0.42, I(2 =) 3%). Subgroup analyses showed that study characteristics such as study design, menopausal status of the women, follow-up duration, diagnostic criteria for prediabetes, methods for validation of BC cases, and study quality scores did not significantly affect the results (p for subgroup analyses all > 0.05). CONCLUSION: Women with prediabetes may not be associated with an increased risk of BC as compared to women with normoglycemia.
format Online
Article
Text
id pubmed-10544966
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-105449662023-10-03 Prediabetes and the risk of breast cancer: a meta-analysis Lin, Jing Tu, Rongzu Lu, Zhai’e Front Oncol Oncology BACKGROUND: Diabetes has been related to a higher risk of breast cancer (BC) in women. However, it remains unknown whether the incidence of BC is increased in women with prediabetes. A systematic review and meta-analysis was therefore performed to evaluate the relationship between prediabetes and risk of BC. METHODS: Observational studies with longitudinal follow-up relevant to the objective were found via searching Medline, Embase, Cochrane Library, and Web of Science. A fixed- or random-effects model was used to pool the results depending on heterogeneity. RESULTS: Eight prospective cohort studies and two nest case-control studies were included. A total of 1069079 community women were involved, and 72136 (6.7%) of them had prediabetes at baseline. During a mean duration follow-up of 9.6 years, 9960 (0.93%) patients were diagnosed as BC. Pooled results with a fixed-effects model showed that women with prediabetes were not associated with a higher incidence of BC as compared to those with normoglycemia (risk ratio: 0.99, 95% confidence interval: 0.93 to 1.05, p = 0.72) with mild heterogeneity (p for Cochrane Q test = 0.42, I(2 =) 3%). Subgroup analyses showed that study characteristics such as study design, menopausal status of the women, follow-up duration, diagnostic criteria for prediabetes, methods for validation of BC cases, and study quality scores did not significantly affect the results (p for subgroup analyses all > 0.05). CONCLUSION: Women with prediabetes may not be associated with an increased risk of BC as compared to women with normoglycemia. Frontiers Media S.A. 2023-09-18 /pmc/articles/PMC10544966/ /pubmed/37790752 http://dx.doi.org/10.3389/fonc.2023.1238845 Text en Copyright © 2023 Lin, Tu and Lu https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Lin, Jing
Tu, Rongzu
Lu, Zhai’e
Prediabetes and the risk of breast cancer: a meta-analysis
title Prediabetes and the risk of breast cancer: a meta-analysis
title_full Prediabetes and the risk of breast cancer: a meta-analysis
title_fullStr Prediabetes and the risk of breast cancer: a meta-analysis
title_full_unstemmed Prediabetes and the risk of breast cancer: a meta-analysis
title_short Prediabetes and the risk of breast cancer: a meta-analysis
title_sort prediabetes and the risk of breast cancer: a meta-analysis
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10544966/
https://www.ncbi.nlm.nih.gov/pubmed/37790752
http://dx.doi.org/10.3389/fonc.2023.1238845
work_keys_str_mv AT linjing prediabetesandtheriskofbreastcancerametaanalysis
AT turongzu prediabetesandtheriskofbreastcancerametaanalysis
AT luzhaie prediabetesandtheriskofbreastcancerametaanalysis